vitamin k 3 has been researched along with Leucocythaemia in 9 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Leukemia lymphocytes were more sensitive to combined administration of anticancer drug (everolimus or barasertib) plus vitamins C and K3, compared to normal lymphocytes." | 7.88 | Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib. ( Aoki, I; Bakalova, R; Getsov, P; Ivanova, D; Lazarova, D; Zhelev, Z, 2018) |
| "The flavonoid quercetin and menadione (vitamin K3) are known as potent apoptogens in human leukemia Jurkat T cells." | 7.80 | Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells. ( Babes, R; Baran, I; Dimancea, A; Filippi, A; Ganea, C; Goicea, A; Iftime, A; Ionescu, D; Irimia, R; Mocanu, MM; Neagu, A; Popescu, V; Tofolean, IT, 2014) |
| "Leukemia lymphocytes were more sensitive to combined administration of anticancer drug (everolimus or barasertib) plus vitamins C and K3, compared to normal lymphocytes." | 3.88 | Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib. ( Aoki, I; Bakalova, R; Getsov, P; Ivanova, D; Lazarova, D; Zhelev, Z, 2018) |
| "The flavonoid quercetin and menadione (vitamin K3) are known as potent apoptogens in human leukemia Jurkat T cells." | 3.80 | Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells. ( Babes, R; Baran, I; Dimancea, A; Filippi, A; Ganea, C; Goicea, A; Iftime, A; Ionescu, D; Irimia, R; Mocanu, MM; Neagu, A; Popescu, V; Tofolean, IT, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Asami, S | 1 |
| Suzuki, M | 1 |
| Nakayama, T | 1 |
| Shimoda, Y | 1 |
| Miura, M | 1 |
| Kato, K | 1 |
| Tokuda, E | 1 |
| Ono, S | 1 |
| Kawakubo, T | 1 |
| Nishizawa, K | 1 |
| Yamanaka, K | 1 |
| Suzuki, T | 1 |
| Ivanova, D | 1 |
| Zhelev, Z | 1 |
| Lazarova, D | 1 |
| Getsov, P | 1 |
| Bakalova, R | 1 |
| Aoki, I | 1 |
| Ibrahim, M | 1 |
| Mendis, N | 1 |
| Roma, A | 1 |
| Jayanth, P | 1 |
| Minden, MD | 1 |
| Spagnuolo, PA | 1 |
| Baran, I | 3 |
| Ionescu, D | 1 |
| Filippi, A | 1 |
| Mocanu, MM | 3 |
| Iftime, A | 1 |
| Babes, R | 1 |
| Tofolean, IT | 1 |
| Irimia, R | 1 |
| Goicea, A | 1 |
| Popescu, V | 1 |
| Dimancea, A | 1 |
| Neagu, A | 1 |
| Ganea, C | 3 |
| Scordino, A | 2 |
| Musumeci, F | 2 |
| Barresi, V | 2 |
| Tudisco, S | 1 |
| Privitera, S | 2 |
| Grasso, R | 2 |
| Condorelli, DF | 2 |
| Ursu, I | 2 |
| Baran, V | 1 |
| Katona, E | 1 |
| Gulino, M | 2 |
| Ungureanu, R | 1 |
| Surcel, M | 1 |
| Ursaciuc, C | 1 |
| Yeo, HS | 1 |
| Shehzad, A | 1 |
| Lee, YS | 1 |
| Garaiman, A | 1 |
| Musso, N | 1 |
| Cirrone, GA | 1 |
| Cuttone, G | 1 |
| Verrax, J | 1 |
| Delvaux, M | 1 |
| Beghein, N | 1 |
| Taper, H | 1 |
| Gallez, B | 1 |
| Buc Calderon, P | 1 |
| Hill, JW | 1 |
| Evans, MK | 1 |
9 other studies available for vitamin k 3 and Leucocythaemia
| Article | Year |
|---|---|
Apoptotic Effects of a Thioether Analog of Vitamin K
Topics: Antineoplastic Agents; Apoptosis; Humans; Jurkat Cells; Leukemia; Phosphorylation; Vitamin K 3 | 2021 |
Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib.
Topics: Antineoplastic Agents; Apoptosis; Ascorbic Acid; Cell Survival; Cells, Cultured; Everolimus; Humans; | 2018 |
Anti-leukemia effect of vitamin K3 is mediated through mitochondrial complexes I and II.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Electron T | 2019 |
Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells.
Topics: Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Humans; Jurkat | 2014 |
Effects of menadione, hydrogen peroxide, and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Flow Cytometry; Humans; Hydrogen Peroxide; Ju | 2010 |
Prostaglandin E2 blocks menadione-induced apoptosis through the Ras/Raf/Erk signaling pathway in promonocytic leukemia cell lines.
Topics: Apoptosis; Cell Survival; Cell Transformation, Neoplastic; Cyclic AMP-Dependent Protein Kinases; Din | 2012 |
Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoids.
Topics: Apoptosis; Catechin; Cell Cycle; Cell Survival; Clone Cells; Flavonoids; Humans; Hydrogen Peroxide; | 2012 |
Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study.
Topics: Adenosine Triphosphate; Apoptosis; Ascorbic Acid; Caspase 3; Caspases; Cell Line, Tumor; Free Radica | 2005 |
A novel R229Q OGG1 polymorphism results in a thermolabile enzyme that sensitizes KG-1 leukemia cells to DNA damaging agents.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alleles; Amino Acid Substitution; Antineoplastic Agents; Cell Line, Tum | 2007 |